| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | PRIMA-1-Met | CTRPv2 | pan-cancer | AAC | 0.28 | 4e-06 |
| mRNA | VU0155056 | CTRPv2 | pan-cancer | AAC | 0.14 | 0.0002 |
| mRNA | tigecycline | CTRPv2 | pan-cancer | AAC | 0.18 | 0.001 |
| mRNA | NSC632839 | CTRPv2 | pan-cancer | AAC | 0.096 | 0.004 |
| mRNA | BRD-K17060750 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.006 |
| mRNA | BRD-K71781559 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.007 |
| mRNA | navitoclax:gemcitabine (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.086 | 0.009 |
| mRNA | clofarabine | CTRPv2 | pan-cancer | AAC | 0.073 | 0.01 |
| mRNA | BRD-K50799972 | CTRPv2 | pan-cancer | AAC | 0.095 | 0.01 |
| mRNA | blebbistatin | CTRPv2 | pan-cancer | AAC | 0.25 | 0.01 |